Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Lunai Bioworks Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 39 | 1 | 50 | +12 |
| Shares | 14.2M | 3.66M | 14.8M | +4.25M (+40.4%) |
| Value | $24.8M | $6.40M | $7.13M | −$11.2M (−61.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Lunai Bioworks Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 3,613,702 | $1.75M | 0.00% |
| Cantor Fitzgerald, L. P. | 100,000 | $48.3K | 0.00% |
| HSBC Holdings PLC | 55,191 | $26.5K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 23,627 | $11.4K | 0.00% |
| Two Sigma Investments, LP | 22,459 | $10.9K | 0.00% |
| JustInvest LLC | 22,285 | $10.8K | 0.00% |
| XTX Topco Ltd | 19,213 | $9.29K | 0.00% |
| SG Americas Securities, LLC | 17,635 | $9.00K | 0.00% |
| Paloma Partners Management Co | 16,954 | $8.19K | 0.00% |
| Tower Research Capital LLC (TRC) | 16,534 | $7.99K | 0.00% |
| Susquehanna International Group, LLP | 16,042 | $7.75K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 12,370 | $5.98K | 0.00% |
| FMR LLC | 4,035 | $1.95K | 0.00% |
| Sterling Capital Management LLC | 89 | $43 | 0.00% |
| Nisa Investment Advisors, LLC | 81 | $39 | 0.00% |
| CNB Bank | 15 | $7 | 0.00% |
| CWM, LLC | 153 | $0 | 0.00% |
Sold out (5)
Institutions that held Lunai Bioworks Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Alpine Global Management, LLC | 46,782 | $81.9K |
| Toroso Investments, LLC | 32,708 | $57.2K |
| Two Sigma Securities, LLC | 16,804 | $29.4K |
| Dimensional Fund Advisors LP | 10,289 | $18.0K |
| Lazard Asset Management LLC | 105 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Lunai Bioworks Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,656,954 | $6.40M |